Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coeptis Therapeutics Holdings (COEP) Non-cash Items (2023 - 2024)

Coeptis Therapeutics Holdings (COEP) has 2 years of Non-cash Items data on record, last reported at $1.1 million in Q1 2024.

  • For Q1 2024, Non-cash Items fell 14.65% year-over-year to $1.1 million; the TTM value through Mar 2024 reached $1.1 million, down 14.65%, while the annual FY2023 figure was $1.2 million, N/A changed from the prior year.
  • Non-cash Items reached $1.1 million in Q1 2024 per COEP's latest filing, down from $1.2 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $1.3 million in Q1 2023 and bottomed at $1.1 million in Q3 2023.